Astrazeneca
-
AI-Built Cancer Antibodies on the Horizon, Potentially Replacing Chemotherapy with AstraZeneca, Absci Collaboration
-
Oxford, AstraZeneca’s Nasal COVID Vaccine Failed to Deliver—Going Back to Development Phase?
-
AstraZeneca COVID Drug Has Monoclonal Antibodies to Prevent Infection, Gets FDA Authorization
-
Expensive AstraZeneca COVID-19 Vaccine May Happen as Expert Says Manufacturer Didn't Make Much Profit
-
COVID-19 Vaccine for Children Ages 5 to 11 Years Old May Come Soon from Manufacturers, as Requested by the FDA—Is it Safe?
-
Johnson & Johnson, AstraZeneca COVID-19 Vaccine Developers Claim Modifications Could Reduce Blood Clotting Risk
-
AstraZeneca COVID-19 Vaccine Protects More Against Delta, Kappa Variants Like Pfizer
-
COVID-19 Vaccine: Study Shows Less Risks of Virus Infection After First Dose, Also for Coronavirus Variants
-
New Study Reveals Mixing of AstraZeneca, Pfizer Vaccine is Safe: Will this Mean 'Double Protection' for COVID-19?
-
50-Year-Old Woman from Alberta Dies After Receiving AstraZeneca Vaccine; Medical Officer Says it is Linked to VITT
-
Pfizer, AstraZeneca Vaccine Side Effects Are Not Too Bad, Study Suggests
-
European Union Files Lawsuit to AstraZeneca Over Vaccine Delivery Delays--What Happened?
Most Popular
